About KWS BioTest
KWS BioTest is a company based in Bristol (United Kingdom) founded in 2011 was acquired by Charles River Laboratories in January 2018. The company has 48 employees as of June 30, 2019. KWS BioTest operates in a competitive market with competitors including Abingdon Health, Spear Bio, Olink, Virtue Diagnostics and Eclipse Bio, among others.
- Headquarter Bristol, United Kingdom
- Employees 48 as on 30 Jun, 2019
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Kws Biotest Limited
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
48
as on Jun 30, 2019
-
Acquired by
Charles River Laboratories
(Jan 11, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of KWS BioTest
Detailed funding history for KWS BioTest
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in KWS BioTest
KWS BioTest has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Charles River Laboratories.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provider of drug discovery and preclinical development services
|
Locked | Locked | Locked |
Investor details for KWS BioTest
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by KWS BioTest
Investment portfolio details for KWS BioTest
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - KWS BioTest
Detailed financials for KWS BioTest
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Kws Biotest Comparisons
Peer comparison for KWS BioTest
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of KWS BioTest
KWS BioTest operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abingdon Health, Spear Bio, Olink, Virtue Diagnostics and Eclipse Bio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of immunoassays for diagnostic purposes
|
|
| Locked | Locked | Locked |
Developer of ultrasensitive immunoassays and proteomics platforms for detecting protein biomarkers
|
|
| Locked | Locked | Locked |
Provider of products and services for human protein biomarker research and development
|
|
| Locked | Locked | Locked |
An in vitro assay platform is provided for diagnostic solutions.
|
|
| Locked | Locked | Locked |
Cell-free immunoassays are developed to identify RNA binding protein targets.
|
|
| Locked | Locked | Locked |
Correlia Biosystems is focused on protein quantification technology.
|
Detailed competitors of KWS BioTest
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Kws Biotest
Complete news archive for KWS BioTest
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about KWS BioTest
KWS BioTest was founded in 2011.
KWS BioTest is headquartered in Bristol, United Kingdom. It is registered at Bristol, England, United Kingdom.
Trevor Langley is the current CEO of KWS BioTest.
As of Jun 30, 2019, the latest employee count at KWS BioTest is 48.
KWS BioTest was established in 2011 in Bristol, United Kingdom, within the biotechnology sector. In vitro and in vivo studies are conducted, focusing on immunology, inflammation, and infection areas. Bioanalytical services, vaccine development support, and related testing operations are offered to clients in these fields. The companys activities are centered on preclinical research and development needs.
KWS BioTest's top competitors include Abingdon Health, Eclipse Bio and Spear Bio.
KWS BioTest has 1 investor. Key investors include Charles River Laboratories.